• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒进化动力学的差异

The Differences in the Evolutionary Dynamics of MERS and SARS Coronaviruses.

作者信息

Ding Yushan, Liu Jiameng, Sabir Jamal S M, Cui Xinyuan, Shen Xuejuan, Hajrah Nahid H, Ahmed Mohamed M M, Sabir Meshaal J, Al-Zogabi Onaizan Godian, Irwin David M, Shen Yongyi

机构信息

State Key Laboratory for Animal Disease Control and Prevention, Center for Emerging and Zoonotic Diseases, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.

Guangzhou Zoo & Guangzhou Wildlife Research Center, Guangzhou 510070, China.

出版信息

Viruses. 2025 Aug 13;17(8):1114. doi: 10.3390/v17081114.

DOI:10.3390/v17081114
PMID:40872828
Abstract

SARS-CoV and MERS-CoV are two coronaviruses that have received significant attention due to their high pathogenicity and mortality rates in human populations. In this study, we compared their evolutionary dynamics to provide a One Health perspective on their differences in terms of the results of disease control. The phylogenetic network of SARS-CoVs showed that human isolates gathered into a "super-spreader" cluster and were distinct from civet isolates. In contrast, dromedary camel- and human-isolated MERS-CoVs were clustered together. Thus, most clades of MERS-CoV can infect humans, and MERS-CoVs seem to more easily spill over the animal-to-human interface. Additionally, the civet can be easily controlled, while the intermediate host (dromedary camels) of MERS-CoV is an important livestock species, so it is impossible to eliminate all animals. This further leads to difficulties in disease control in MERS. Although MERS-CoVs are endemic to dromedary camels in both the Middle East and Africa, human infections are mainly linked to the Middle East. The nucleotide sequences of the MERS-CoV receptor gen (dipeptidyl peptidase 4 (DPP4)) from 30 Egyptians, 36 Sudanese, and 34 Saudi Arabians showed little difference. These findings suggest that the observed disparities in MERS prevalence between populations in the Middle East and Africa may be more strongly attributed to inadequate disease surveillance and the limited camel-to-human transmission of clade C MERS-CoV in Africa, rather than variations in gene.

摘要

严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV)是两种冠状病毒,因其在人群中的高致病性和死亡率而备受关注。在本研究中,我们比较了它们的进化动态,以便从“同一个健康”的角度就疾病控制结果方面的差异提供见解。SARS-CoV的系统发育网络显示,人类分离株聚集形成一个“超级传播者”簇,且与果子狸分离株不同。相比之下,单峰骆驼分离的MERS-CoV和人类分离的MERS-CoV聚集在一起。因此,MERS-CoV的大多数进化枝都能感染人类,而且MERS-CoV似乎更容易跨越动物与人之间的界面传播。此外,果子狸易于控制,而MERS-CoV的中间宿主(单峰骆驼)是一种重要的家畜物种,所以不可能消灭所有动物。这进一步导致中东呼吸综合征疾病控制方面的困难。尽管MERS-CoV在中东和非洲的单峰骆驼中都是地方流行,但人类感染主要与中东有关。来自30名埃及人、36名苏丹人和34名沙特阿拉伯人的MERS-CoV受体基因(二肽基肽酶4(DPP4))的核苷酸序列差异不大。这些发现表明,中东和非洲人群中观察到的中东呼吸综合征流行率差异可能更多地归因于疾病监测不足以及非洲C进化枝MERS-CoV从骆驼到人的传播有限,而非基因变异。

相似文献

1
The Differences in the Evolutionary Dynamics of MERS and SARS Coronaviruses.中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒进化动力学的差异
Viruses. 2025 Aug 13;17(8):1114. doi: 10.3390/v17081114.
2
Ongoing Evolution of Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, 2023-2024.2023 - 2024年沙特阿拉伯中东呼吸综合征冠状病毒的持续演变
Emerg Infect Dis. 2025 Jan;31(1):57-65. doi: 10.3201/eid3101.241030. Epub 2024 Dec 6.
3
Low-Level Zoonotic Transmission of Clade C MERS-CoV in Africa: Insights from Scoping Review and Cohort Studies in Hospital and Community Settings.非洲C型中东呼吸综合征冠状病毒的低水平人畜共患传播:来自医院和社区环境范围审查及队列研究的见解
Viruses. 2025 Jan 17;17(1):125. doi: 10.3390/v17010125.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
A single-dose intranasal immunization with a novel bat influenza A virus-vectored MERS vaccine provides effective protection against lethal MERS-CoV challenge.用一种新型甲型蝙蝠流感病毒载体中东呼吸综合征疫苗进行单剂量鼻内免疫可有效抵御致死性中东呼吸综合征冠状病毒攻击。
mBio. 2025 Jun 30:e0110725. doi: 10.1128/mbio.01107-25.
6
Development and preliminary validation of a MERS-CoV ELISA for serological testing of camels and alpacas.MERS-CoV ELISA 的研制及初步验证——用于骆驼和羊驼血清学检测。
J Virol Methods. 2024 Jun;327:114923. doi: 10.1016/j.jviromet.2024.114923. Epub 2024 Mar 30.
7
Exceptional diversity and selection pressure on coronavirus host receptors in bats compared to other mammals.与其他哺乳动物相比,冠状病毒宿主受体在蝙蝠中表现出非凡的多样性和选择压力。
Proc Biol Sci. 2022 Jul 27;289(1979):20220193. doi: 10.1098/rspb.2022.0193.
8
and characterization of a bat merbecovirus with ACE2- and DPP4-independent cell entry.以及一种具有不依赖ACE2和DPP4的细胞进入方式的蝙蝠美贝病毒的特征描述。
J Virol. 2025 Jul 22;99(7):e0072725. doi: 10.1128/jvi.00727-25. Epub 2025 Jun 17.
9
Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment.在动物模型中,通过治疗给药,有效的 3CLpro 抑制剂对 SARS-CoV-2 和 MERS-CoV 有效。
mBio. 2024 Feb 14;15(2):e0287823. doi: 10.1128/mbio.02878-23. Epub 2023 Dec 21.
10
Characterization of a MERS-related betacoronavirus in Danish brown long-eared bats (Plecotus auritus).丹麦棕长耳蝠(Plecotus auritus)中一种与中东呼吸综合征相关的β冠状病毒的特征分析。
Virol J. 2025 Aug 18;22(1):283. doi: 10.1186/s12985-025-02883-8.

本文引用的文献

1
Update on the Epidemiology of Middle East Respiratory Syndrome Coronavirus - Worldwide, 2017-2023.2017 - 2023年全球中东呼吸综合征冠状病毒流行病学最新情况
MMWR Morb Mortal Wkly Rep. 2025 May 29;74(19):313-320. doi: 10.15585/mmwr.mm7419a1.
2
Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses with spillover risk.对具有外溢风险的利用ACE2的中东呼吸综合征相关冠状病毒的全球监测及应对措施。
Cell. 2025 Mar 20;188(6):1465-1468. doi: 10.1016/j.cell.2025.02.004.
3
Regulation of miRNA in Cytokine Storm (CS) of COVID-19 and Other Viral Infection: An Exhaustive Review.
新型冠状病毒肺炎及其他病毒感染细胞因子风暴中miRNA的调控:详尽综述
Rev Med Virol. 2025 Mar;35(2):e70026. doi: 10.1002/rmv.70026.
4
Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses.中东呼吸综合征相关冠状病毒中ACE2使用的多次独立获得
Cell. 2025 Mar 20;188(6):1693-1710.e18. doi: 10.1016/j.cell.2024.12.031. Epub 2025 Feb 7.
5
Dysregulation of lung epithelial cell homeostasis and immunity contributes to Middle East respiratory syndrome coronavirus disease severity.肺上皮细胞稳态和免疫失调会导致中东呼吸综合征冠状病毒疾病的严重程度增加。
mSphere. 2025 Feb 25;10(2):e0095124. doi: 10.1128/msphere.00951-24. Epub 2025 Jan 30.
6
Low-Level Zoonotic Transmission of Clade C MERS-CoV in Africa: Insights from Scoping Review and Cohort Studies in Hospital and Community Settings.非洲C型中东呼吸综合征冠状病毒的低水平人畜共患传播:来自医院和社区环境范围审查及队列研究的见解
Viruses. 2025 Jan 17;17(1):125. doi: 10.3390/v17010125.
7
Ongoing Evolution of Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, 2023-2024.2023 - 2024年沙特阿拉伯中东呼吸综合征冠状病毒的持续演变
Emerg Infect Dis. 2025 Jan;31(1):57-65. doi: 10.3201/eid3101.241030. Epub 2024 Dec 6.
8
Saudi Arabia's Middle East respiratory syndrome Coronavirus (MERS-CoV) outbreak: consequences, reactions, and takeaways.沙特阿拉伯中东呼吸综合征冠状病毒(MERS-CoV)疫情:后果、反应及启示
Ann Med Surg (Lond). 2024 Jul 1;86(8):4668-4674. doi: 10.1097/MS9.0000000000002336. eCollection 2024 Aug.
9
Recombination as an evolutionary driver of MERS-related coronavirus emergence.重组作为中东呼吸综合征相关冠状病毒出现的进化驱动力。
Lancet Infect Dis. 2024 Sep;24(9):e546. doi: 10.1016/S1473-3099(24)00461-4. Epub 2024 Jul 24.
10
HLA-DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID-19 pneumonia.HLA-DQA1*01:03 和 DQB1*06:01 是重症 COVID-19 肺炎的危险因素。
HLA. 2024 Jul;104(1):e15609. doi: 10.1111/tan.15609.